H. F. Cabanos

Cycling cancer persister cells arise from lineages with distinct programs

A. Regev, M. Tabaka, K. Politi, 2021, Nature.

Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer

A. Hata, H. F. Cabanos, 2021, Cancers.

APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer

Christopher J. Ott, Jake June-Koo Lee, Chang S. Chan, 2021, bioRxiv.

Cycling cancer persister cells arise from lineages with distinct transcriptional and metabolic programs

A. Regev, M. Tabaka, J. Brugge, 2020, bioRxiv.

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Christopher J. Ott, Chang S. Chan, M. Lawrence, 2023, Nature.